ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 120 filers reported holding ENZO BIOCHEM INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $127,000 | -89.4% | 15,674 | -86.3% | 0.01% | -89.0% |
| Q3 2017 | $1,201,000 | +1.2% | 114,790 | +6.7% | 0.08% | -5.7% |
| Q2 2017 | $1,187,000 | +246.1% | 107,576 | -7.6% | 0.09% | +262.5% |
| Q1 2015 | $343,000 | -41.3% | 116,370 | -11.6% | 0.02% | -38.5% |
| Q4 2014 | $584,000 | -19.2% | 131,646 | -6.2% | 0.04% | -17.0% |
| Q3 2014 | $723,000 | -25.9% | 140,413 | -24.5% | 0.05% | -27.7% |
| Q2 2014 | $976,000 | – | 186,003 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |